Skip to main content

Table 1 Study inclusion and exclusion criteria according to groups

From: Progranulin signaling in sepsis, community-acquired bacterial pneumonia and COVID-19: a comparative, observational study

Criteria

Sepsis

SIRS

Pneumonia

Localized infection

Healthy controls

Inclusion

Sepsis or septic shock according to SEPSIS-3 criteria [15]

Systemic inflammatory response after major surgery and cardiopulmonary bypass (modified SEPSIS-2 criteria)

ICU or IMC patients with community-acquired pneumonia without recent hospitalization or association with other healthcare facilities such as nursing homes, dialysis centers, and outpatient clinics

Clinical symptoms like fever, cough or dyspnea and a CURB-65 score ≥ 1 were required for diagnosis

ICU/IMC patients with large peripheral tissue infections (e.g., abscess formation after i.v. drug abuse)

Charlson Comorbidity Index = 0 [41]

Exclusion

No consent given by patients or next-of-kin

Age < 18

Pregnancy

Preexisting chronic infectious disorders (e.g., endocarditis, HIV or hepatitis)

Current tumor or malignant disorders

Limited patient’s life expectancy < 6 months (independent of, e.g., sepsis/SIRS, pneumonia or localized infection)

Immunosuppressiona

  1. ICU  intensive care unit, IMC intermediate care
  2. aPatients being on steroid therapy, autoimmune disease, transplantation or other immunocompromising conditions like HIV or leukemia